| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester LE3 9PQ, UK
Correspondence to:
Correspondence to:
Dr I D Pavord, Institute for Lung Health, Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester LE3 9PQ, UK;
trina.raftery{at}uhl-tr.nhs.uk
Background: The debate as to whether asthma is a single or heterogeneous disease remains unresolved although pathological studies, mostly using fibreoptic bronchoscopy on small numbers of subjects, have emphasised the similarities between different clinical phenotypes.
Methods: Lower airway inflammation was assessed non-invasively using induced sputum in 34 normal controls and 259 adults with symptomatic asthma receiving treatment at steps 1–3 of the British Thoracic Society (BTS) guidelines. A subgroup of 49 patients treated with as required ß2 agonists only who met BTS criteria for a step up in treatment were studied before and 2 months after treatment with inhaled budesonide 400 µg twice daily.
Results: There was considerable heterogeneity in induced sputum cell counts, particularly in non-atopic patients. A subgroup of 60 patients had a distinctive sputum cell profile with a neutrophil count higher than our normal range (>65.3%) and a normal sputum eosinophil count (<1.9%). These patients were older, predominantly female, and were more likely to be non-atopic but otherwise had similar clinical and physiological features to the group as a whole. Among the 49 subjects studied before and after inhaled budesonide, 11 patients had an isolated sputum neutrophilia. Following treatment, these patients showed significantly less improvement in visual analogue symptom scores (–5.5 v –19.4 mm; mean difference 13.9; 95% CI 0.7 to 27.0), forced expiratory volume in 1 second (FEV1) (–0.08 v 0.13 l; mean difference 0.21; 95% CI 0.03 to 0.39), and concentration of methacholine provoking a fall in FEV1 of 20% or more (PC20) (0.15 v 1.29 doubling doses; mean difference 1.11; 95% CI 0.13 to 2.15) than the remaining 38 patients.
Conclusions: These results suggest the presence of a distinct subgroup of patients with mild to moderate asthma who have predominantly neutrophilic airway inflammation and who respond less well to treatment with inhaled corticosteroids.
Keywords: asthma; induced sputum; neutrophilic inflammation
This article has been cited by other articles:
|
|
 |
|
  K. Ito, C. Herbert, J. S. Siegle, C. Vuppusetty, N. Hansbro, P. S. Thomas, P. S. Foster, P. J. Barnes, and R. K. Kumar Steroid-Resistant Neutrophilic Inflammation in a Mouse Model of an Acute Exacerbation of Asthma Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 543 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Gray, G. MacGregor, D. Noble, M. Imrie, M. Dewar, A. C. Boyd, J. A. Innes, D. J. Porteous, and A. P. Greening Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. T. Sutherland, J. O. Cowan, S. Young, A. Goulding, A. M. Grant, A. Williamson, K. Brassett, G. P. Herbison, and D. R. Taylor The Association between Obesity and Asthma: Interactions between Systemic and Airway Inflammation Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 469 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Erin, G. R. Jenkins, O. M. Kon, A. S. Zacharasiewicz, G. C. Nicholson, H. Neighbour, R. C. Tennant, A. J. Tan, B. R. Leaker, A. Bush, et al. Optimized Dialysis and Protease Inhibition of Sputum Dithiothreitol Supernatants Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 132 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Shaw, M. A. Berry, B. Hargadon, S. McKenna, M. J. Shelley, R. H. Green, C. E. Brightling, A. J. Wardlaw, and I. D. Pavord Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma Chest, December 1, 2007; 132(6): 1871 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, L. Brannick, D. Robinson, S. Wenzel, W. Busse, T. T. Hansel, et al. A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1062 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Berry, A. Morgan, D. E Shaw, D. Parker, R. Green, C. Brightling, P. Bradding, A. J Wardlaw, and I. D Pavord Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma Thorax, December 1, 2007; 62(12): 1043 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Maestrelli Same role and same treatment for airway eosinophilia in asthma and COPD? Eur. Respir. J., May 1, 2007; 29(5): 831 - 833. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Lloyd and D. S. Robinson Allergen-induced airway remodelling Eur. Respir. J., May 1, 2007; 29(5): 1020 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D Pavord Non-eosinophilic asthma and the innate immune response Thorax, March 1, 2007; 62(3): 193 - 194. [Full Text] [PDF]
|
|
|
|
|
|
J. L Simpson, T. V Grissell, J. Douwes, R. J Scott, M. J Boyle, and P. G Gibson Innate immune activation in neutrophilic asthma and bronchiectasis Thorax, March 1, 2007; 62(3): 211 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Knox and J Britton Thorax 1996-2002 Thorax, December 1, 2006; 61(12): 1020 - 1021. [Full Text] [PDF]
|
|
|
|
|
|
D. Proud and C.-W. Chow Role of Viral Infections in Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu Recommendations for the management of cough in adults Thorax, September 1, 2006; 61(suppl_1): i1 - i24. [Full Text] [PDF]
|
|
|
|
|
|
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Reddel and D. J. Barnes Pharmacological strategies for self-management of asthma exacerbations. Eur. Respir. J., July 1, 2006; 28(1): 182 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Balfour-Lynn, B. Lees, P. Hall, G. Phillips, M. Khan, M. Flather, J. S. Elborn, and on behalf of the CF WISE (Withdrawal of Inhaled St Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma Chest, May 1, 2006; 129(5): 1194 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Clinical Applications of Induced Sputum Chest, May 1, 2006; 129(5): 1344 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Wenzel and R. Covar Update in asthma 2005. Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706. [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling Sputum Induction in Asthma Chest, March 1, 2006; 129(3): 503 - 504. [Full Text] [PDF]
|
|
|
|
|
|
E. Bacci, S. Cianchetti, M. Bartoli, F. L. Dente, A. Di Franco, B. Vagaggini, and P. Paggiaro Low Sputum Eosinophils Predict the Lack of Response to Beclomethasone in Symptomatic Asthmatic Patients Chest, March 1, 2006; 129(3): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Park, M. T. Wiekowski, S. A. Lira, and B. Mehrad Neutrophils Regulate Airway Responses in a Model of Fungal Allergic Airways Disease J. Immunol., February 15, 2006; 176(4): 2538 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Parameswaran Treatment Strategy for Asthma: One for All and All for One? Chest, February 1, 2006; 129(2): 221 - 223. [Full Text] [PDF]
|
|
|
|
|
|
P Ernst Inhaled corticosteroids moderate lung function decline in adults with asthma Thorax, February 1, 2006; 61(2): 93 - 94. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Simpson, R. J. Scott, M. J. Boyle, and P. G. Gibson Differential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 559 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wenzel Severe Asthma in Adults Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 149 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A V Kamath, I D Pavord, P R Ruparelia, and E R Chilvers Is the neutrophil the key effector cell in severe asthma? Thorax, July 1, 2005; 60(7): 529 - 530. [Full Text] [PDF]
|
|
|
|
|
|
L Jayaram, E Pizzichini, C Lemiere, S F P Man, A Cartier, F E Hargreave, and M M M Pizzichini Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast Thorax, February 1, 2005; 60(2): 100 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.K. Reddel Goals of asthma treatment: how high should we go? Eur. Respir. J., November 1, 2004; 24(5): 715 - 717. [Full Text] [PDF]
|
|
|
|
|
|
N.C. Thomson, R. Chaudhuri, and E. Livingston Asthma and cigarette smoking Eur. Respir. J., November 1, 2004; 24(5): 822 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Wenzel Phenotypes in Asthma: Useful Guides for Therapy, Distinct Biological Processes, or Both? Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 579 - 580. [Full Text] [PDF]
|
|
|
|
|
|
A. ten Brinke, A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel "Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 601 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-W. Perng, H.-Y. Huang, H.-M. Chen, Y.-C. Lee, and R.-P. Perng Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD: A Potential Guide to Treatment Chest, August 1, 2004; 126(2): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Cosio, B. Mann, K. Ito, E. Jazrawi, P. J. Barnes, K. F. Chung, and I. M. Adcock Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Archer, J. L. H. Cramton, J. C. Pfau, G. Colasurdo, and A. Holian Airway responsiveness after acute exposure to urban particulate matter 1648 in a DO11.10 murine model Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L337 - L343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chaudhuri, E. Livingston, A. D. McMahon, L. Thomson, W. Borland, and N. C. Thomson Cigarette Smoking Impairs the Therapeutic Response to Oral Corticosteroids in Chronic Asthma Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1308 - 1311. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
